NCBiotech News

Five North Carolina startups are headed to High Point University this week to compete in the Venture Pitch Showcase with the goal of being named the North Carolina Biotechnology Center’s NC BIONEER Venture Challenge winner.

Novozymes and AgroFresh have announced a collaboration in which they'll be working together to find sustainable solutions that keep foods fresher, longer, after harvest and reduce product loss.

Following two years of development, Astellas’ new late-stage clinical and commercial manufacturing plant officially opened its doors in Sanford.

The White House is closely reviewing North Carolina’s COVID response to glean “best practice” for pandemic preparedness going forward.

A drug produced by BioCryst Pharmaceuticals of Durham has won regulatory approval in Canada and Switzerland for preventing hereditary angioedema (HAE), a rare disease of swollen tissues caused by excessive fluid buildup.

Two whopping life sciences “gets” helped put North Carolina in a special award status in the current issue of Area Development, a quarterly publication covering site selection, facility planning, and economic development.

Biotalys’ new biofungicide Evoca has received the World BioProtection Award for Best Biofungicide.

Wilmington-based Renaissance Fiber will represent the state’s southeastern region at the North Carolina Biotechnology Center’s Venture Pitch Showcase at Triad BioNight in High Point next month.

To comply with regulatory requriments under the Transparency in Coverage Rule issued by the U.S. Department of Health & Human Services, U.S. Department of Labor and U.S. Department of the Treasury, NCBiotech is disclosing transparent pricing information for health care services.

TARGAN, a Morrisville biotech startup that is focused on revolutionizing current vaccination methods for the commercial poultry industry, has landed an additional $35 million in funding.

Morrisville gene editing startup Locus Biosciences is another step closer to actualizing its biotherapeutics against bacterial diseases after landing $35 million in additional capital.

Labcorp’s new at-home collection kit is a threefer. It simultaneously tests for COVID-19, respiratory syncytial virus (RSV) and the flu, too.

When the pandemic caused Frankie Spinks to lose her job, she found a new career opportunity in biomanufacturing through the BioWork certificate program at Central Carolina Community College.

The keynote speaker, co-chairs, events team and awards committee have been selected for the June 23 Triad BioNight 2022.

Durham's Kriya Therapeutics just added $270 million to its coffers, bringing its total raised to date to roughly $450 million for novel gene therapies